(13:16 GMT) Tenax Therapeutics Price Target Maintained With a $27.00/Share by Chardan Capital
Dow Jones Newswires
Tenax Therapeutics Is Maintained at Buy by Chardan Capital
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:TENX
- Language
- English